by Annabel Sedgwick
Share
by Annabel Sedgwick
Share
Anion dysregulation is seen in numerous diseases, from cystic fibrosis and chronic pain, to autism and cancer. Researchers at the University of Dallas are investigating anion transport in vivo, developing novel tools to help analyze the effects of both normal and aberrant anion regulation at the molecular level, and are using INTEGRA’s PIPETBOY acu 2 to streamline their cell culture workflows. Whitney Ong, a joint chemistry graduate student in the Dodani and Smaldone labs at the university, explained: “My research focuses on the development of supramolecular-based sensors for anions, particularly for chloride. The reason we are especially interested in chloride is that it is the most abundant anion in the human body – serving all sorts of functions – and its dysregulation is implicated in diseases such as cystic fibrosis. We’re hoping that our chloride sensing platform could help in its detection, as well as in the diagnosis of a number of other diseases.”
Whitney continued: “We have three PIPETBOY pipette controllers and use them regularly for a variety of tasks during our cell culture set-up, for instance to make up large volumes of cell culture media, aliquoting and dispensing reagents such as media or antibiotics, resuspensions, as well as to mix different solutions. If we are working with volumes of liquids above 2 ml, we will always use the PIPETBOY; it’s much easier, safer and more efficient that pouring liquids between glass measuring cylinders, where there is a higher risk of spillages or not pouring out the desired volume. They fit into our workflows perfectly – everyone in the lab loves them.”
Visit the INTEGRA Biosciences website to learn more.
About INTEGRA Biosciences
INTEGRA Biosciences (https://www.integra-biosciences.com) is a leading provider of high-quality laboratory tools and consumables for liquid handling and media preparation. The company is committed to creating innovative solutions which fulfil the needs of its customers in research, diagnostics and quality control within the life sciences markets and medical sector. Today, INTEGRA innovative laboratory products are widely used all around the world. More than 100 distribution partners form a worldwide sales network providing responsive and competent services to customers. These distribution partners are supported by a highly motivated and experienced team of specialists at the company headquarters in Zizers, Switzerland and Hudson, NH, USA. INTEGRA is an ISO 9001 certified company.
Microban® International – the global leader in antimicrobial additives and odor control solutions – has released a statement discrediting unwarranted claims about the safety and efficacy of antimicrobial technologies. This statement is intended to ensure that the public, consumers, and other stakeholders are equipped to make fully informed decisions, based on scientific reasoning. Making a clear distinction between public health and non-public health claims, Microban has explained the advantages of incorporating its antimicrobial additives into
June Medical is one of 48 organisations to be recognised for their excellence in innovation in this year’s Queen’s Awards for Enterprise. Now in its 55th year, the Queen’s Awards for Enterprise are the most prestigious business awards in the country – rewarding only the most outstanding achievements – with winning businesses able to use the esteemed
A report from the International Agency for Research on Cancer1 recently classified TiO2 as ‘possibly carcinogenic to humans’ by inhalation and similarly, the European Chemicals Agency2 recommended TiO2 be classified as a category 2 carcinogen (suspected of causing cancer). In contrast, antimicrobial technologies from Microban International are based on SilverShield®, the first patented antimicrobial solution
INTEGRA Biosciences’ VIAFLO electronic pipettes are helping denovoMATRIX in Dresden, Germany, to produce modular, biomimetic coatings for cell culture plasticware that can be tailored to recreate a large variety of conditions for testing adherent cell cultures. Chief Scientific Officer Dr Richard Wetzel explained: “We have developed a range of pre-coated cell culture plasticware – screenMATRIX and myMATRIX – and